Literature DB >> 27015719

Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.

William B Brinkman1, Rebecca Baum2, Kelly J Kelleher2, James Peugh3, William Gardner4, Phil Lichtenstein5, Joshua Langberg6, Jeffery N Epstein3.   

Abstract

OBJECTIVE: To describe the relationships between attention-deficit/hyperactivity disorder (ADHD) care practices and subsequent medication use.
METHOD: A retrospective cohort from a random sample of medical records in 50 pediatric practices with 188 providers, including 1,352 children who started ADHD medication, was studied. Independent variables included physician behaviors related to medication titration and monitoring of treatment response. Primary outcomes were number of days covered with ADHD medication during the first year of treatment and time from starting medicine to the first 30-day gap in medication supply. Multilevel modeling and Cox proportional hazards regression models were conducted.
RESULTS: Children had an average medication supply of 217 days in the first year. Half experienced a 30-day gap in medication supply in the first 3 months. Nearly three-fourths had a medication adjustment in the first year with the first adjustment usually being a dosage change. The average time to the first medication adjustment was over 3 months. Physician's first contact with parents occurred in the first month of treatment for less than half, with the average time being over 2 months. Little variation related to ADHD care quality was accounted for at the physician level. Early titration and early contact were related to greater medication supply and continuity of treatment.
CONCLUSION: Earlier physician-delivered ADHD care (e.g., contact with parent after starting medication and medication adjustment) is related to greater medication supply and continuity. It remains to be determined whether interventions that improve the quality of titration and monitoring practices for children with ADHD would also improve medication continuity.
Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adherence; attention-deficit/hyperactivity disorder; clinical practice guidelines; pharmacotherapy; quality of care

Mesh:

Year:  2016        PMID: 27015719      PMCID: PMC4808569          DOI: 10.1016/j.jaac.2016.02.001

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  22 in total

1.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  An observational study of pharmacological treatment in primary care of children with ADHD in the United kingdom.

Authors:  Sudha R Raman; Stephen W Marshall; Bradley N Gaynes; Kevin Haynes; A Jackson Naftel; Til Stürmer
Journal:  Psychiatr Serv       Date:  2015-03-01       Impact factor: 3.084

3.  Small sample inference for fixed effects from restricted maximum likelihood.

Authors:  M G Kenward; J H Roger
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

4.  Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.

Authors:  Steven C Marcus; George J Wan; Jason E Kemner; Mark Olfson
Journal:  Arch Pediatr Adolesc Med       Date:  2005-06

5.  Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

Authors:  D Thiruchelvam; A Charach; R J Schachar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

6.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  Stimulant treatment over five years: adherence, effectiveness, and adverse effects.

Authors:  Alice Charach; Abel Ickowicz; Russell Schachar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-05       Impact factor: 8.829

8.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

Authors: 
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

9.  Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.

Authors:  Emily R Cox; Brenda R Motheral; Rochelle R Henderson; Doug Mager
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

10.  Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.

Authors:  Amy Perwien; Jennifer Hall; Andrine Swensen; Ralph Swindle
Journal:  J Manag Care Pharm       Date:  2004 Mar-Apr
View more
  13 in total

1.  The Role of Parental Knowledge and Attitudes about ADHD and Perceptions of Treatment Response in the Treatment Utilization of Families of Children with ADHD.

Authors:  Rosanna Breaux; Daniel A Waschbusch; Rebecca Marshall; Hugh Humphrey; William E Pelham; James G Waxmonsky
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2020-03-24

2.  ADHD Medication Adherence in College Students-A Call to Action for Clinicians and Researchers: Commentary on "Transition to College and Adherence to Prescribed Attention Deficit Hyperactivity Disorder Medication".

Authors:  Tanya E Froehlich
Journal:  J Dev Behav Pediatr       Date:  2018-01       Impact factor: 2.225

3.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

4.  Primary Care Management of Children with Attention-Deficit/Hyperactivity Disorder Appears More Assertive Following Brief Psychiatric Intervention Compared with Single Session Consultation.

Authors:  Carol M Rockhill; L Lee Carlisle; Pingping Qu; Ann Vander Stoep; William French; Chuan Zhou; Kathleen Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-03-11       Impact factor: 2.576

5.  Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.

Authors:  William B Brinkman; John O Simon; Jeffery N Epstein
Journal:  Acad Pediatr       Date:  2017-09-12       Impact factor: 3.107

6.  Effects of Collaborative Care for Comorbid Attention Deficit Hyperactivity Disorder Among Children With Behavior Problems in Pediatric Primary Care.

Authors:  David J Kolko; Jonathan A Hart; John Campo; Dara Sakolsky; Jeffrey Rounds; Mark L Wolraich; Stephen R Wisniewski
Journal:  Clin Pediatr (Phila)       Date:  2020-07       Impact factor: 1.168

7.  Six Stages of Engagement in ADHD Treatment Described by Diverse, Urban Parents.

Authors:  Andrea E Spencer; Jennifer Sikov; J Krystel Loubeau; Nicole Zolli; Tithi Baul; Megan Rabin; Syeda Hasan; Katherine Rosen; Olivia Buonocore; Julia Lejeune; Rohan Dayal; Lisa Fortuna; Christina Borba; Michael Silverstein
Journal:  Pediatrics       Date:  2021-09-16       Impact factor: 9.703

Review 8.  National Child Mental Health Quality Measures: Adherence Rates and Extent of Evidence for Clinical Validity.

Authors:  Bonnie T Zima; Juliet B Edgcomb; Samantha A Shugarman
Journal:  Curr Psychiatry Rep       Date:  2019-01-31       Impact factor: 5.285

9.  Strategies for improving ADHD medication adherence.

Authors:  Kelly I Kamimura-Nishimura; William B Brinkman; Tanya E Froehlich
Journal:  Curr Psychiatr       Date:  2019-08

10.  Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.

Authors:  Joseph C Blader; Steven R Pliszka; Vivian Kafantaris; Carmel A Foley; Gabrielle A Carlson; Judith A Crowell; Brigitte Y Bailey; Colin Sauder; W Burleson Daviss; Christa Sinha; Thomas L Matthews; David M Margulies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-01-30       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.